Notice ID: c0afe74686bf48419ebaac5f93e696c3Combined Synopsis/Solicitation
NCI Patterns of Care (POC) Study: Diagnosis Year 2021 (Prostate Cancer and Ovarian Cancer)
Archived on March 29, 2024. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 12:00 PM UTC−04:00
- Posted
- March 6, 2024
- Notice type
- Combined Synopsis/Solicitation
- NAICS
- 541990: All Other Professional, Scientific, and Technical Services
- Agency
- Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH
Notice details
- Office
- NIH NCI
- Last updated
- Dec 4, 2025
Identifiers
- Solicitation number
- 75N91023Q00142
- Notice ID
- c0afe74686bf48419ebaac5f93e696c3
Description
AMENDMENT 3 IS ISSUED TO EXTEND THE DUE DATE FOR SUBMISSION OF QUOTES TO MARCH 14, 2024, 12PM ET. Amendment 3 is provided in the ATTACHMENTS section of this posting. Quoters are required to acnowledge each Solicitation Amendment by including each Standard Form (SF-30) signed by your organizations signature authority and completing Block 8 with your Organization Name and Address, and submitting it along with your quote submission. *************************************************************************************** AMENDMENT 2 was ISSUED TO EXTEND THE DUE DATE FOR SUBMISSION OF QUOTES. Amendment 2 is provided in the ATTACHMENTS section of this posting. Quoters are required to acnowledge each Solicitation Amendment by including each Standard Form (SF-30) signed by your organizations signature authority and completing Block 8 with your Organization Name and Address, and submitting it along with your quote submission. *************************************************************************************** 2/20/2024: Reuploaded the file "RFQ75N91023Q00142 w attachments_FINAL 2 Feb 2024" since prior uploaded version appeared to have been corrupted and couldn't be accessed. It is a duplicate file and no changes were made. Amendment 1 of the Solication attached. Amendment 1 extended the Due Date for Submission of Quotes. It also provided Answers to Solicitations Questions. Quoters are required to acnowledge each Solicitation Amendment by including each Standard Form (SF-30) signed by your organizations signature authority and completing Block 8 with your Organization Name and Address, and submitting it along with your quote submission. **************************************************************************************** The purpose of this acquisition is to collect data for the National Cancer Institute (NCI) Patterns of Care (POC) FY2024 Study. The NCI Pattern of Care studies describe, characterize, and compare practice patterns and treatments provided for cancer in different geographic areas of the United States. This solicitation for the FY 2024 NCI Patterns of Care Study is investigating patterns of care for patients with prostate and ovarian cancers for Diagnosis Year 2021. The study will also collect data on documentation of palliative care and patient financial impacts of the COVID-19 pandemic in the medical record. The primary objectives of this POC Study are to: 1) describe the use of recommended biomarker tests which shall be verified with the treating physician/physician office staff or with a unified medical record (record with all inpatient and outpatient records in a single file) or complete medical records (all inpatient and outpatient cancer treatment records obtained from more than one hospital/healthcare system/medical practice); 2) describe the use of targeted therapy which shall be verified with the treating physician/physician office staff or with a unified or complete medical record. 3) describe the use of adjuvant therapy, which shall be verified with the treating physician/physician office staff or with a unified or complete medical records; 4) characterize the practice patterns in different communities; 5) compare the patterns of treatment (surgery, radiation therapy, systemic therapy (chemotherapy, immunotherapy, hormonal therapy, targeted therapy, and other adjuvant therapy) over time and by age, sex, race/ethnicity, and insurance status; 6) describe comorbidities and the effect of co-morbid conditions on treatment; 7) describe treatment by hospital characteristics (i.e., for profit vs. not for profit, teaching vs. non-teaching, bed size, etc.); 8) describe the use of diagnostic tests and compare their use by demographic variables; 9) abstract information documented in the medical record on delays or changes in diagnosis, treatment, and supportive/palliative care among individuals diagnosed with cancer specifically due to the COVID-19 pandemic; 10) assess the incidence of cancer recurrence and metastasis following initial diagnosis; and 11) describe medical record documentation of patient financial impacts due to the COVID-19 pandemic potentially affecting cancer care. SEE ATTACHED REQUEST FOR QUOTE that contains all the relevant attachments. Word/editable versions of some of those attachments have also been attached separately for ease of quote preparation purposes (but are exact duplicates of what is already in the full "RFQ 75N91023Q00142 w Attachments" file.)
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
75N91023Q00142- Combined Synopsis
- 5×Combined SynopsisCurrentFeb 2, 2024
NCI Patterns of Care (POC) Study: Diagnosis Year 2021 (Prostate Cancer and Ovarian Cancer)
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
This is not a solicitation announcement. This is a Sources Sought Notice (SSN) only. This SSN is issued solely for market research and planning purposes – it does not constitute a Request for Proposal (RFP) or a promise to issue an RFP in the future. Further, the SSN does not commit the Government to contract for any supply or service whatsoever. The FDA is not seeking proposals and will not accept any unsolicited proposals. Responders are advised that the U.S. Government will not pay for any information or administrative costs incurred in response to this SSN; all costs associated with responding to this SSN will be solely at the expense of the interested respondents. Not responding to this SSN does not preclude participation in any future RFP, if issued. The purpose of this sources sought synopsis is to gain knowledge of potential qualified vendors to include potential 8(a) vendors 8(a) relative to the North American Industry Classification System (NAICS) code and capable of providing multidisciplinary scientific and regulatory professional services in support of FDA Centers and Offices. Responses to this Sources Sought Notice will be used by the Government to make appropriate determinations about potential sources. Project Title: FDA Scientific and Regulatory Support Services (SRS) IDIQ Background/Overview: The Food and Drug Administration (FDA) is a science-based regulatory agency critically important to the stability of the nation's public health and health care systems. FDA protects and promotes the health and safety of all Americans by enhancing the availability of safe medical products, foods, and animal products, and by promoting innovation that addresses unmet medical and public health needs. FDA decisions must be based on the best available scientific data and employ the best tools and methods available to ensure products meet the highest quality standards, while fostering innovation in the products it regulates. In support of its regulatory mission, FDA conducts scientific research across a broad range of disciplines including vaccines, drug safety, food safety, medical devices, biologics, toxicology, radiological products, and more. FDA's science is increasingly data-centric, complex, and collaborative, involving multidisciplinary groups across its Centers and Offices. Within the Center for Drug Evaluation and Research (CDER), the Office of Computational Science (OCS), established under the Office of Translational Sciences, supports the data management, technical, and analytic needs of the regulatory review process. OCS manages and supports analytical tools, data standards, and computing infrastructure that form the backbone of modern regulatory review for medical products. Purpose: The FDA is seeking information from experienced sources in Scientific and Regulatory Support Services as it is contemplating the establishment of a Indefinite Delivery Indefinite Quantity (IDIQ) to such services. The FDA’s primary objective for this effect is to obtain Contractor services related to scientific and regulatory support across a broad range of mission requirements. Depending on the requirement, services may support scientific research, regulatory review, clinical and non-clinical analyses, epidemiology and surveillance, scientific data interpretation, laboratory activities, technical writing, training, and scientific program coordination. Objectives: The objective of the contemplated SRS acquisition is to provide FDA with responsive, high-quality scientific and regulatory support across a broad range of mission requirements. Depending on the task order, services may support scientific research, regulatory review, clinical and nonclinical analyses, epidemiology and surveillance, scientific data interpretation, laboratory activities, technical writing, training, and scientific program coordination. The Government is interested in sources capable of providing the scientific depth and operational capacity needed to: Conduct scientifically sound analyses and prepare defensible, traceable technical products supporting FDA review and public-health decisions. Provide qualified personnel across multiple scientific and regulatory disciplines, including specialized and emerging areas. Support clinical and nonclinical study-data review, standardized scientific datasets, statistical computing, data fitness, quality assessment, and interpretation. Respond to multiple simultaneous task orders, changing priorities, time-sensitive scientific questions, and evolving requirements across FDA organizations. Maintain scientific quality, data integrity, documentation, confidentiality, and continuity of performance. Deliver effective scientific training, technical writing, knowledge transfer, and program-management support tied directly to scientific and regulatory missions. Project Requirements: The following descriptions are illustrative of the types of services that may be ordered. They are provided to inform industry responses and do not establish final task-order requirements. Each task order would define its own objectives, tasks, deliverables, performance expectations, staffing qualifications, and period of performance. Scientific Research and Regulatory Review Support: Support scientific investigations, literature and evidence reviews, research planning, study design, methodological assessments, scientific consultations, and technical analyses relevant to FDA-regulated products. Prepare scientific assessments, briefing materials, review support documentation, and other products that allow Government scientists and reviewers to evaluate scientific evidence and communicate findings. Provide subject-matter expertise to address complex or emerging regulatory science questions. Clinical and Nonclinical Study-Data Review and Analysis: Support the scientific review of clinical and nonclinical datasets submitted for regulatory purposes, including data fitness and completeness assessments, exploratory safety analyses, descriptive and inferential statistical analyses, and preparation of tables, listings, figures, and visualizations. Experience with standards such as CDISC SDTM, ADaM, and SEND may be relevant. The RRS BPA describes review-oriented services that assess study data and produce analyses for FDA reviewers; SRS would focus on the scientific and analytical performance of those services rather than maintenance of the underlying software platforms. Epidemiology, Biostatistics, Pharmacovigilance, and Surveillance: Conduct epidemiological and Pharmacoepidemiological research, biostatistical analyses, pharmacovigilance assessments, signal detection and evaluation, public-health surveillance, and interpretation of real-world data and evidence as required by individual scientific programs. Activities may include protocol and analysis-plan support, assessment of study limitations and bias, statistical programming, results interpretation, and technical reporting. Scientific Data Standards, Quality, and Analytics: Provide scientific expertise related to data standards, controlled terminology, study-data interpretation, data quality and fitness, and reproducible analytical methods. Support scientific data preparation and validation, biostatistics, bioinformatics, computational science, and other specialized analyses when the primary deliverable is scientific or regulatory in nature. Distinguish these activities from enterprise database administration, application development, platform engineering, and IT operations. Laboratory and Specialized Scientific Support: Provide laboratory-related scientific and technical expertise, research assistance, analytical method support, study coordination, quality documentation, and interpretation or reporting of laboratory findings where required by a task order. Respondents should identify the specific laboratory disciplines, facilities, qualifications, and methods they can support rather than assume that all clinical trial operations or laboratory testing will be included. Scientific Writing, Training, Knowledge Management, and Communications: Develop scientific reports, regulatory review support materials, technical summaries, study documentation, research publications, presentations, training curricula, and knowledge-transfer materials. Provide specialized scientific and regulatory training, including instruction related to study-data standards and analytical methods. Communications and knowledge-management work should be directly connected to scientific or regulatory activities rather than general enterprise communications or IT support. Scientific Program and Project Management: Plan and coordinate scientific studies and projects; manage milestones, deliverables, schedules, staffing, and technical reporting; facilitate multidisciplinary collaboration; track performance and quality; and support continuity during transitions. Such activities must be integral to scientific and regulatory service delivery, not standalone enterprise IT project management. Scope Distinctions: The contemplated SRS acquisition is not intended to replace vehicles for enterprise IT architecture, systems or application development, cloud or data-platform operations, infrastructure administration, software maintenance, generalized service-desk support, or other predominantly IT functions. Where a task combines scientific analysis and enabling technology, the Government will determine the appropriate vehicle and scope based on the primary purpose of the requirement. The final boundary between SRS and remaining RRS or other vehicles is subject to FDA and OAGS confirmation. Capabilities and Technical Experience: Interested small businesses should submit a concise capability statement demonstrating relevant, actual performance and capacity to satisfy the contemplated requirements. Responses should clearly distinguish capabilities performed by the respondent from those provided by subcontractors, affiliates, or proposed teaming partners. FDA is particularly interested in the following: Relevant Experience: Describe comparable scientific and regulatory engagements, customer organizations, contract or order identifiers where releasable, approximate value, period of performance, work performed, disciplines supported, and measurable outcomes. Explain how the experience relates to the breadth and complexity of the contemplated SRS work. Scientific and Regulatory Disciplines: Describe the service areas the respondent can perform, with concrete examples involving scientific research, regulatory analysis, clinical/nonclinical datasets, statistical methods, epidemiology, laboratory work, scientific writing, and training as applicable. Do not claim disciplines for which experience cannot be substantiated. Workforce and Concurrent Delivery Capacity: Describe the organization's demonstrated ability to recruit, retain, and deploy highly specialized scientific and regulatory professionals across a broad range of disciplines, including individuals with advanced degrees, niche technical expertise, and experience supporting complex scientific and regulatory programs. FDA recognizes that certain highly specialized skill sets may require recruitment from an international talent pool, including individuals holding or requiring employment-based visa sponsorship (e.g., H-1B) or other appropriate work authorization. Respondents should describe their experience recruiting and retaining such personnel, managing applicable sponsorship and work authorization requirements, and mitigating potential staffing disruptions during contract transitions. Responses should also address the organization's ability to fill hard-to-recruit positions, maintain continuity of specialized expertise, accommodate surge requirements, and support multiple concurrent task orders. Scientific Quality and Data Practices: Describe scientific quality-control procedures, independent review, data integrity and reproducibility practices, use of applicable scientific standards, confidentiality controls, and experience handling sensitive regulatory or research information. Representative Complex Requirement: Describe one or more specific scientific or regulatory assignments presenting substantial technical complexity, urgent timelines, or multidisciplinary coordination. Explain the challenge, approach, expertise, deliverables, and outcomes. Teaming and Prime-Contractor Role: Describe anticipated prime, subcontracting, joint-venture, or teaming arrangements and the work each participant would perform. Explain how the prime would exercise management and technical oversight while meeting applicable small-business requirements. Contract Structure Feedback: Identify whether the firm could support the full breadth of contemplated services or a defined subset and explain why. Instructions for Responses: Your responses to the questions provided below will assist the Government in selecting the appropriate acquisition method. Page limit: Maximum 15 pages (font size Times New Roman 11 or larger). A copy of the company capability statement will also be accepted (but not in place of the responses to the below questions). The anticipated period of performance is a 5-year ordering period. After review of the responses received, a pre-solicitation synopsis and formal solicitation may be published on SAM.gov. In addition to responses to the below questions, each vendor responding to this SSN shall also fill out and provide responses to “Attachment B-Vendor Feedback Form.” The Vendor Feedback Form is not included in the 15-page limit. A copy of the company capability statement will also be accepted (but not in place of the responses to the below questions or the Vendor Feedback Form). Responses to this notice must include company name, address, point of contact, size of business pursuant to the NAICS code, and must respond to the following questions: Is your business a small business under the NAICS code? Is your firm certified under Section 8(a) of the Small Business Act? Included is a draft Statement of Work that is inclusive of the anticipated Task Areas (Attachment A). All interested parties can provide written opinions on the draft Statement of Work. All opinions expressed should focus on strengthening the draft Statement of Work Tasks to ensure industry understands and comprehends the government’s requirements. Business Status Provide the legal business name and address Primary point of contact and the contact information SAM.gov Unique Entity Identifier (UEI) CAGE code Proposed NAICS code and size status Applicable small-business socioeconomic designations (including 8(a), HUBZone, service-disabled veteran-owned, veteran-owned, women-owned, or small disadvantaged business, as applicable) Identify whether the respondent proposes to participate as prime contractor, joint venture, or subcontractor Responses to this notice shall be submitted via e-mail to Amanda Edger, Contract Specialist, at Amanda.Edger@fda.hhs.gov (with a CC: to Ian Weiss, Contracting Officer, at Ian.Weiss@fda.hhs.gov), by November 19, 2026, at 2:00 pm. After a review of the received responses, a pre-solicitation synopsis and formal solicitation may be published on SAM.gov. No solicitation is currently available. This is not a request for proposals and in no way obligates the Government to award any contract. Responses to this Sources Sought Notice will not be considered adequate responses to the solicitation, a request to be added to a prospective offerors list, or a request to receive a copy of the solicitation. Ref. No. FDA-RFI-75F40127R00007/ALP No. OMITS-2027-136942. | - | Market Research | 11/23/2026 |
SOURCES SOUGHT NOTICE NIH SCIENTIFIC & TECHNICAL EXPERTISE ACQUISITION & MANAGEMENT (STEAM) Sources Sought Reference Number: 75N98027R00012 Proposed NAICS Code and Size Standard: 541990 — All Other Professional, Scientific and Technical Services; $19.5 million in average annual receipts Sources Sought Notice Information Introduction This is a Small Business Sources Sought notice. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding: (1) the availability and capability of qualified small business sources; (2) their small business and applicable socioeconomic status, including HUBZone, service-disabled veteran-owned, veteran-owned, 8(a), woman-owned, and small disadvantaged business status; and (3) their size classification relative to the proposed North American Industry Classification System (NAICS) code. Responses will assist the Government in determining the appropriate acquisition method, including whether a full or partial small business set-aside is appropriate. Interested small businesses may respond for Task Area A (Professional Services), Task Area B (Highly Specialized Scientific Services), or both. Respondents should identify their ability to perform as a prime contractor, joint venture, or subcontracting team, distinguish their own capability from that of team members, and identify limitations within each task area addressed. NIH will assess capability separately for each area. Capability in both areas is not required to respond. The Government has not made a final set-aside determination. Background The National Institutes of Health (NIH) conducts and supports biomedical and behavioral research to advance scientific knowledge and improve health. NIH requires professional, scientific, and technical contractor support for current and emerging research priorities, ongoing research activities, and related program operations. Changes in research programs and scientific methods create a continuing need for flexible service delivery and specialized expertise. Scientific & Technical Expertise Acquisition & Management (STEAM) will acquire contractor-provided services and expertise to accomplish varied project-based requirements across NIH. Individual task orders will define project objectives, tasks, deliverables or milestones, performance periods, required expertise, and resource needs. Contractors must furnish and manage the resources needed to perform multiple concurrent projects at substantial volume and adjust those resources as authorized project requirements change. NIH anticipates using cost-reimbursement contracting approximately 20 percent of the time. The actual mix will depend on individual requirements. Firms should describe their experience and ability to support this component, including any preparation needed. Existing cost-reimbursement capability or a prior Government accounting-system approval is not a mandatory condition of responding to this notice. Applicable requirements, including accounting-system adequacy, would need to be satisfied before award of a cost-reimbursement order. Purpose and Objectives The purpose of STEAM is to provide professional, scientific, and technical support for NIH research and related activities. Support includes basic, translational, and clinical research; vaccine research; general and specialized laboratory research; veterinary and animal research support; bioinformatics; computational biology; and related professional and technical services. The contractor will furnish and manage qualified resources to accomplish each statement of work (SOW), including responsibility for recruiting, verifying qualifications, retaining its personnel, and maintaining continuity of performance. Services will be furnished under individual funded, project-based task orders. The contractor will furnish resources, including personnel with expertise corresponding to the applicable labor categories, to accomplish the SOW and deliver the required project outcomes and milestones. The contractor will retain responsibility for employing, supervising, and managing its personnel. Services will not include inherently governmental functions or unauthorized personal services. Each task order will identify the applicable task area, project scope, qualifications, location, performance schedule, and security and safety requirements. Project Requirements Services may involve expertise in microbiology, molecular biology, biochemistry, infectious diseases, immunology, clinical research, bioinformatics, genomic sequencing, proteomics, image analysis, computational and systems biology, and scientific data analysis. Related requirements may include clinical trials support, laboratory operations, veterinary services, program management, and other professional or technical support within the authorized scope. Qualifications range from positions without a degree requirement to licensed practitioners and highly specialized doctoral-level professionals. The contractor must be able to furnish qualified resources within the task area or areas addressed and manage a substantial volume of concurrent project requirements. Primary anticipated locations include Bethesda and Rockville, Maryland; other locations in the Washington, DC metropolitan area; and Hamilton, Montana. Other domestic locations, overseas support, travel, or remote work may be authorized by individual orders. NIH-wide demand for task orders and contractor support fluctuates across projects, locations, and time. This notice does not provide a fixed annual volume estimate or guarantee a minimum workload. Routine task orders will establish mobilization, onboarding, and performance start schedules. Under certain circumstances, an urgent or unforeseen NIH need may require the contractor to begin authorized performance within 48 hours. For an expedited request, NIH will identify the applicable timeframe and the event from which it is measured. Respondents should describe their ability to accommodate these requests, identify the categories and locations they could support, and explain any limitations or prerequisites. Contractors must ensure that their personnel have the qualifications and relevant experience required for the assigned work and complete applicable training, competency verification, occupational health requirements, and facility-specific access approvals before beginning restricted work. For assignments involving regulated select agents or toxins, applicable individual access approvals, security risk assessments, and required training must be completed before access. Prior experience at another laboratory does not establish authorization at the receiving NIH facility. An expedited task-order request does not waive these prerequisites. The following 156 labor-category families are organized into two task areas. Each family appears once. Categories encompass applicable levels and specialties; task orders will specify required duties and qualifications. Numbered levels are not automatically equivalent to Junior, Mid-Level, or Senior designations. The task-area structure supports market research and does not establish the final award structure. Task Area A — Professional Services This area covers general professional, management, administrative, business, IT, and technical support for NIH projects, including project coordination, financial analysis, enterprise systems, and related operational services. Scientific versions of otherwise general roles are assigned to Task Area B. Accessibility Specialist Accounting Technician Administration Administrative Support Administrative Support Assistant (Administrative Support) Advisor Agile Consultant Analytics Specialist BMC Administrator BMC Remedy Administrator Budget Analyst Business Process Consultant Business Systems Analyst Communications Specialist Computer Systems Analyst Consultant (Professional) Data Analyst Data Architect Database Administrator Database Analyst/Programmer Editor Engineer (Professional) Executive Consultant Facilities Management Assistant Facilities Planning Manager Facility Support Specialist Financial Analyst Grants Management Executive Graphics Designer/Web Developer Help Desk Manager Help Desk Specialist Help Desk Support Tier IT Data Scientist IT SME Management Analyst Office Manager Paralegal Payroll Support Policy Analyst Procurement Technician Program Analyst Program Assistant Program Manager Program Support Project Coordinator Project Manager Project Support Property Technician QA/QC Records Specialist SharePoint Administrator SharePoint Developer Shipping and Receiving Clerk Software Architect Software Developer Software Engineer Space Management Specialist Subject Matter Expert Systems Engineer Technical Writer Technician Web Designer Web Developer Task Area B — Highly Specialized Scientific Services This area covers scientific research and development, specialized scientific computing and analysis, laboratory services, and all clinical and animal-care roles, including associated routine support. Assignments may support basic, translational, or clinical research and specialized containment environments. Qualification requirements vary by role; not every category requires a doctoral degree or BSL-3 experience. Task Area B may include support for Biosafety Level (BSL) 1, 2, 3, and 4 laboratories and Animal Biosafety Level (ABSL) 1, 2, 3, and 4 environments, as specified in individual task orders. Support for BSL-3 and BSL-4 laboratories remains a significant specialized requirement. Respondents should identify the levels they can support and any limitations. Capability at every level is not required to respond to this notice. Animal Biologist Animal Technician Behavioral Geneticist Biochemist Bioinformatician Bioinformatics Scientist Biological Scientist Biologist Biologist/Microbiologist Bioprocess Engineer Biostatistician Biostatistician/Statistical Programmer Chemical Engineer Cheminformatics Scientist Chemist Chemist/Biochemist Clinical Advisor (Scientific) Clinical Biostatistician Clinical Informatics Project Manager Clinical Operations Manager Clinical Program Manager Clinical Protocol Coordinator Clinical Psychologist Clinical Research Associate Clinical Research Coordinator Clinical Research Pharmacist Clinical Research Support Clinical Social Worker Clinical Trials Admin Cognitive Neuroscientist Computer Scientist Consultant (Scientific) Cytogenetic Technologist Data Manager Data Scientist Echo Technologist Engineer (Scientific) Enzymologist Epidemiologist Genetic Counselor Imaging Specialist Immunologist Laboratory Animal Technician Laboratory Assistant Laboratory Manager Laboratory Operations Specialist Laboratory Technician Medical Assistant Medical Illustrator Medical Officer Medical Records Specialist Medical Records Technician Molecular Geneticist MRI Data Analyst MRI Psychology Researcher MRI Technologist Neurodiagnostic Technologist Nurse (Certified Nursing Assistant) Nurse (Licensed Practical Nurse) Nurse (Registered Nurse Research) Nurse (Registered Nurse) Nurse Practitioner Patient Care Coordinator Patient Coordinator Peer Review Specialist Pharmacologist Pharmacy Technician Specialist Phlebotomist Physician Assistant Physician Policy Researcher Quality Assurance Quality Assurance Analyst Quality Assurance Specialist Recruitment and Outreach Specialist Regulatory Affairs Specialist Research Analyst Research Associate Research Nurse Research Specialist Researcher Robotics Engineer Science Writer/Editor Scientific Data Manager Scientific Data Specialist Scientific Policy Analyst Scientific Program Analyst Scientific Program Manager Scientific Researcher Scientific Review Officer Scientist Statistician Technical Writer, Scientific Veterinarian Anticipated Period of Performance NIH anticipates a five-year ordering period, from April 2027 through April 2032, subject to final acquisition strategy. Individual orders will establish their own authorized performance periods. Planning estimates do not guarantee quantities, orders, or a share of work. Capability Statement/Information Sought Submit a separate, clearly labeled capability statement for Task Area A, Task Area B, or each area if responding to both. Each statement should describe the project-based services and labor categories supported, contractor personnel expertise and availability, current capacity, comparable project experience, management capability, and customer references. Identify unsupported categories and limitations. Responses should address the following for each task area selected: (1) Experience managing comparable project-based service contracts and task orders, including the number and type of personnel supported, peak active headcount, concurrent orders or projects, locations, and volume of personnel mobilized to perform the work. Provide up to three relevant examples per task area from the last five years, including ongoing work, and identify the performing entity, customer, period, and reference contact. Federal, commercial, and academic examples may be used. If comparable experience is unavailable, identify other evidence supporting the proposed capability. Apply the recruitment questions below to the task area addressed; scientific recruiting is relevant to scientific assignments. Describe recruitment as the contractor’s responsibility for furnishing resources to perform the SOW. For a response covering both areas, distinguish capacity and lead times by area. (2) The approach to scientific recruiting, qualification and credential verification, retention, replacement of contractor personnel, expansion of project teams during surges, and geographically dispersed workforce management. Provide normal mobilization and personnel replacement timeframes. Separately describe the ability to begin authorized performance in response to urgent requests within 48 hours, with examples where available and an explanation of any Government or facility approvals affecting the start date. Do not assume that all categories or sites require continuous 48-hour response capability. The containment-specific information below applies to respondents offering laboratory or animal-containment support within Task Area B. For each applicable BSL-1 through BSL-4 and ABSL-1 through ABSL-4 level, identify relevant contract performance experience, specialties, annual capacity to mobilize contractor personnel, maximum concurrent contractor personnel assignments, normal recruitment timeframes, and limitations. Distinguish company capability from proposed team-member capability and demonstrated experience from projected capacity. Identify unsupported levels; experience at one level does not establish readiness for another. Cross-reference item (7) without double counting capacity across levels. The following question places particular emphasis on BSL-3 and BSL-4. A-only respondents may identify this item as not applicable. (3) Experience furnishing and managing qualified contractor resources for BSL-3 and BSL-4 laboratories and, where applicable, ABSL-3 or other containment environments. Identify specialties, numbers of contractor personnel supporting performance, and relevant performance examples. Explain how training, competency, occupational health, and access prerequisites are verified and coordinated with the receiving facility. Provide aggregate readiness information without medical records, sensitive laboratory security details, or unnecessary personal information. (4) The management and financial resources available to support the proposed workforce, including supervision, payroll, timekeeping, reporting, quality control, working capital, and transition continuity. Describe cost-reimbursement experience, accounting-system capabilities, any relevant Government reviews, and any preparation needed to support the anticipated cost-reimbursement component. This information is requested for market research and is not a mandatory qualification for responding. (5) The professional qualifications and relevant experience of the respondent's proposed key personnel. Respondents should identify their own key personnel appropriate to managing STEAM and provide resumes reflecting education, relevant work, proposed responsibilities, availability, and competing commitments. NIH is not prescribing a fixed key-personnel roster or a mandatory Principal Investigator position for this notice. Resumes are not required for every potential contractor personnel assignment. (6) The proposed prime, joint venture, and subcontractor roles, including the task areas and assigned categories, expected work shares, commitment status, and the prime's management responsibilities. Identify the ability to meet applicable small-business eligibility and performance requirements if a set-aside is selected. Clearly identify gaps in full-scope coverage and any discrete portions that could be supported separately. (7) Quantified annual and concurrent capacity. Respondents must provide numerical capacity estimates for each task area addressed, with assumptions and supporting evidence. Report task orders (TOs) and contractor personnel assignments separately: a task order may require multiple personnel, and the two measures must not be treated as interchangeable. For these capacity questions, a personnel assignment means one role filled by contractor personnel to perform an order’s SOW; it is a workload measure, not a separate task order or a Government hiring action. (a) Annual capacity: State the maximum number of new task orders the company could accept and perform in a 12-month period, and the maximum total number of task orders it could perform during that period, including orders continuing from prior periods. Separately state the number of new contractor personnel assignments it could mobilize during that period and its capacity to replace personnel while maintaining performance. Distinguish unique assignments from successive replacements in the same role. (b) Concurrent capacity: State the maximum number of active task orders and contractor personnel assignments the company could sustain at the same time. Explain the assumed number and mix of personnel assignments per order, order duration, geographic coverage, and any constraints for specialized scientific or BSL/ABSL assignments at each level offered, where applicable. (c) Available and surge capacity: Account for existing customer commitments and distinguish capacity currently available to NIH from capacity requiring additional hiring, financing, or team members. State the additional task orders and contractor personnel assignments that could be supported during a surge, the time needed to reach that level, and how long it could be sustained. For a response covering both areas, provide a combined achievable total and explain shared resources without double counting. (d) Supporting evidence: Provide actual annual task-order and personnel mobilization volumes and peak concurrent orders and contractor personnel assignments from comparable work within the last five years, identifying the period measured. Cross-reference examples under item (1) to avoid repetition. Distinguish demonstrated performance from projected capacity, explain how estimates were developed, and identify the capacity supplied by the company itself versus proposed joint-venture partners or subcontractors. If comparable history is unavailable, provide other evidence supporting the estimates. Explain the recruiting, management, and financial resources needed to sustain the stated volume. (8) Sources Sought Question. How would your firm fund uninterrupted performance during a surge in workload and a cash-flow stress period of up to 90 days between incurring costs and receiving payment? Briefly identify available or obtainable financing, existing obligations, and mitigation of any shortfall. This information is for market research, not an eligibility determination. Financial Review Statement. The Government intends to examine liquidity, working capital, financing availability, existing obligations, and surge and cash-flow contingency plans against solicitation-specific performance needs. Reasonable alternative evidence of financial capability, including resources obtainable by award, will be considered. Financial capability will be assessed as a responsibility matter in any resulting solicitation and award. The 90-day period is a market-research stress scenario, not a proposed payment term. No binding price proposal is requested. Information Submission Instructions: Page Limitations Capability statements must not exceed five (5) pages per task area, excluding key-personnel resumes. A respondent addressing both areas may submit up to ten (10) narrative pages combined, with separate A and B sections limited to five pages each. Cover pages, business information, tables, and project examples count toward these limits; common business information may be provided once and counted within one area’s limit. Use 10-to-12-point font, at least one-inch margins, and standard letter-size paper (8.5 x 11 inches), with no more than six lines of text per vertical inch. Resumes should be limited to two pages per key person. Internet links may not substitute for requested evidence. Mark proprietary information. Required Business Information: • Unique Entity ID (UEI) and CAGE code, if available. • Company name and physical address. • Technical and administrative points of contact, including names, titles, telephone numbers, and email addresses. • Small-business status under the proposed NAICS code, applicable socioeconomic designations and certification status, and SAM.gov registration status. • Cost-reimbursement capability and accounting-system review status, including the reviewing agency and date, if applicable. An existing Government approval is not required to respond. Number of Copies: Submit one (1) electronic copy of the capability statement and key-personnel resumes in searchable Adobe Portable Document Format (PDF), by email to both contracting contacts listed below. The email subject line must specify sources sought reference number 75N98027R00012 and the company name. The response must identify Task Area A, Task Area B, or both in its cover information and email subject. NIH will post notice amendments and updates on SAM.gov. Common Cut-off Date: Electronically submitted capability statements are due no later than November 15, 2026, at 11:59 p.m. Eastern Standard Time (EST). The Government may issue consolidated responses by amendment. An extension request or pending question does not change the response deadline; only a written Government amendment can do so. Respondents should not assume an extension will be granted. All responses must be received by the stated deadline to be assured consideration. Disclaimer and Important Notes This notice does not obligate the Government to issue a solicitation, award a contract or order, or pay for information provided in response. Responses must be complete and sufficiently detailed to permit assessment of the respondent's capabilities. The Government may request clarification or verify references but is under no obligation to acknowledge receipt or provide individual feedback. Any subsequent solicitation will contain the governing requirements and instructions. A response to this notice will not substitute for a response to a solicitation. Confidentiality Clearly identify proprietary information. Information will be handled in accordance with applicable law. Do not submit classified information, sensitive laboratory security information, medical records, or unnecessary personal information. Identify supporting records requiring a Government-approved secure channel rather than attaching them to ordinary email. Contracting Office Address Department of Health and Human Services National Institutes of Health Division of Strategic Sourcing Office of Logistics and Acquisition Operations (OLAO) NIH Office of Acquisition and Logistics Management (OALM) 6701B Rockledge Drive Bethesda, Maryland 20817 Points of Contact: Kishan Patel, Contracting Officer Email: kishan.patel@nih.gov Alternate contact: Som Bahrami, Contracting Officer Email: som.bahrami@nih.gov | - | Market Research | 11/15/2026 |
Title: SMART IRB Governance, Administration, and Operations Support (GAOS) This is a combined synopsis/solicitation for commercial items/services prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) FAR Subpart 13.5—Simplified Procedures for Certain Commercial Items; and FAR Part 12— Acquisition of Commercial Items; and is expected to exceed the simplified acquisition threshold. Introduction and Background Objectives The National Center for Translational Sciences (NCATS) requires a partner to facilitate user administration, process/workflow improvements, content development/moderation, requirements gathering, and dissemination of the SMART IRB (Streamlined, Multisite, Accelerated Resources for Trials Institutional Review Board) portfolio of services. SMART IRB relies on three systems: (1) the SMARTIRB.org website which is used for content distribution, notification, and educational purposes, (2) Joinder, through which institutions enter institutional information and sign the SMART IRB Authorization Agreement (AA), and (3) the Online Reliance System (ORS), through which Institutional Review Board (IRB) reliance arrangements under the SMART IRB Agreement are documented on a study-by-study basis. The selected partner will provide support in accordance with this SOW to aid in the facilitation and growth of SMART IRB. Please see the attached RFQ 75N98026Q00287 for more details | - | Combined Synopsis | 11/13/2026 |
| - | Awarded | Open | |
THIS SOURCES SOUGHT IS FOR INFORMATIONAL PURPOSES ONLY. THIS IS NOT A REQUEST FOR PROPOSAL. IT DOES NOT CONSTITUTE SOLICITATION AND SHALL NOT BE CONSTRUED AS A COMMITMENT BY THE GOVERNMENT. RESPONSES IN ANY FORM ARE NOT OFFERS AND THE GOVERNMENT IS UNDER NO OBLIGATION TO AWARD A CONTRACT AS A RESULT OF THIS ANNOUNCEMENT. NO FUNDS ARE AVAILABLE TO PAY FOR PREPARATION OF RESPONSES TO THIS ANNOUNCEMENT. ANY INFORMATION SUBMITTED BY RESPONDENTS TO THIS TECHNICAL DESCRIPTION IS STRICTLY VOLUNTARY. The Naval Air Systems Command, PMA-262 (Program Office for MQ-4C Unmanned Aircraft System (UAS)), is soliciting information from industry to determine potential contractors who have the skills, experience, qualifications, and knowledge to provide the comprehensive engineering, logistics, material, maintenance, program management, and operational support required to successfully provide the sustaining and reach back engineering support needed to sustain the United States Navy and Royal Australian Air Force (RAAF) MQ-4C Triton UAS at both Contiguous United States (CONUS) and Outside the Contiguous United States (OCONUS) locations. This effort includes up to higher than Secret classification level of support. Northrop Grumman Systems Corporation (NGSC) is the original designer, developer, and manufacturer of the MQ-4C Triton UAS. As such they possess the requisite technical data and knowledge to meet the Navy’s requirements for sustaining engineering support of the MQ-4C UAS. The contractor shall be responsible for obtaining from NGSC all manufacturing drawing and proprietary specification data necessary to support the sustainment of the MQ-4C Triton UAS. DISCLAIMER: THIS SOURCES SOUGHT NOTICE ANNOUNCEMENT IS NOT A REQUEST FOR PROPOSAL (RFP), BUT RATHER A REQUEST FOR INFORMATION (RFI) from industry that will allow the Government to identify interested sources capable of meeting the requirements. This RFI is issued solely for market research, planning and information purposes and is not to be construed as a commitment by the Government to enter into a contractual agreement, nor will the Government pay for information solicited hereunder. There is no commitment by the Government to issue a solicitation, make an award, or be responsible for any monies expended by any interested parties in support of the effort mentioned above. Vendors can additionally provide a capabilities statement of no more than five (5) pages in length that demonstrates the respondent’s ability to meet the requirements as specified herein. The Government is interested in receiving vendors’ commercial published price lists for items they believe meet the need in this RFI. All data received in response to this RFI, marked or designated as corporate or proprietary, will be fully protected from release outside the Government. Failure to respond to this RFI does not preclude participation in any future associated RFP that may be issued. Information provided herein is subject to change and in no way binds the Government to solicit or award a contract. If a solicitation is released, it will be synopsized on the System for Award Management (SAM) website: www.sam.gov. It is the potential offeror’s responsibility to monitor this site for the release of any follow-on information. Interested parties are requested to submit a capability statement of no more than five (5) pages in length, demonstrating their ability to provide the specified services. The capability statement should include, at a minimum, the following: Company Name, Company Address, Company Business Size, CAGE code, and Point of Contact (POC) information to include POC’s name, phone number and email address. Relevant past performance / experience. A concise description of the company’s experience providing sustaining engineering, logistics, material, maintenance, program management, and/or operational/reach-back support for military UAS or similarly complex aviation platforms, at CONUS and OCONUS locations. Include at least two specific examples (contract number/customer, period of performance, approximate value, locations, classification level, and a one- or two-sentence description of the work). Experience with High Altitude Long Endurance (HALE) UAS, maritime ISR systems, or OEM-unique designs is of particular interest but is not a prerequisite. Technical data access. Evidence of current access to, or a realistic plan for obtaining, the manufacturing drawings, proprietary specifications, and other technical data necessary to sustain the MQ-4C Triton UAS. Describe any existing data licenses or rights, teaming or subcontracting arrangements with existing data holders, or other approaches. The Government recognizes that most non-OEM sources will need a teaming or licensing path; a credible path is sufficient at this stage. A description of the company's quality assurance processes and certifications. Security and classification capability. Current Facility Clearance (FCL) level and status; approximate number of personnel holding active Secret, Top Secret, and SCI (or equivalent) clearances; experience performing work at classification levels higher than Secret; and a high-level statement of the company’s ability to obtain additional personnel clearances and any required facility accreditations in a timeframe consistent with contract award and performance. Any other relevant information that demonstrates the company's ability to meet the Government's requirements. Responses shall be submitted electronically to the designated Contract Specialist, Lara Chubb, in Microsoft Word format or Portable Document Format (PDF) at the following email address: lara.i.chubb.civ@us.navy.mil (or DOD Safe for larger files). All responses, including capability statements, shall be submitted no later than 5:00 PM EST, 23 November 2026. Questions or comments regarding this notice may be addressed to the Procuring Contracting Officer, Mr. Tyler Summers and Contract Specialist, Ms. Lara Chubb. | - | Market Research | 11/23/2026 |
Additional Details
Solicitation Number
75N91023Q00142
Archive Date
Mar 29, 2024
Office Address
Bethesda, MD, 20892